Cargando…
Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1‐specific immunotherapy using high‐dose CpG adjuvant
BACKGROUND: The prevalence of allergy to cat is expanding worldwide. Allergen‐specific immunotherapy (AIT) has advantages over symptomatic pharmacotherapy and promises long‐lasting disease control in allergic patients. However, there is still a need to improve cat AIT regarding efficacy, safety, and...
Autores principales: | Leonard, Cathy, Montamat, Guillem, Davril, Caroline, Domingues, Olivia, Hunewald, Oliver, Revets, Dominique, Guerin, Coralie, Blank, Simon, Heckendorn, Justine, Jardon, Gauthier, Hentges, François, Ollert, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359185/ https://www.ncbi.nlm.nih.gov/pubmed/33345329 http://dx.doi.org/10.1111/all.14716 |
Ejemplares similares
-
CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance
por: Montamat, Guillem, et al.
Publicado: (2021) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016) -
Suppressive CpG
por: Van Epps, Heather L.
Publicado: (2005) -
Factors to preserve CpG-rich sequences in methylated CpG islands
por: Miyahara, Hiroki, et al.
Publicado: (2015) -
In Vivo Control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases
por: Arand, Julia, et al.
Publicado: (2012)